$MYO SEC Filings

Filed On	Filing
15 Oct 2026	Form 4: Kovelman Harry, Chief Medical Officer Received 32,500 shares as a grant or award
15 Oct 2026	Form 4/A: Kovelman Harry, Chief Medical Officer Sold 15,844 shares ($20.1K)
15 Oct 2026	Form 4: Henry David A, Chief Financial Officer Received 51,250 shares as a grant or award
15 Oct 2026	Form 4: Gudonis Paul R, Director Received 71,250 shares as a grant or award
13 Oct 2026	Form 4: Henry David A, Chief Financial Officer Received 6,272 shares as a grant or award · Gave up 3,133 shares to cover exercise price or tax ($4.29K)
13 Oct 2026	Form 4: Gudonis Paul R, Director Received 8,363 shares as a grant or award
13 Oct 2026	Form 4: McClure Mary-Katherine Hale, Chief Commericial Officer Received 275,000 shares as a grant or award
13 Oct 2026	144
13 Oct 2026	Form 3: McClure Mary-Katherine Hale, Chief Commericial Officer No securities owned
13 Oct 2026	S-8
14 Sep 2026	Form 4: Kovelman Harry, Chief Medical Officer Sold 15,488 shares ($19.7K)
11 Sep 2026	144
04 Sep 2026	Form 4: Morris Milton Mayo, Director Sold 15,000 shares ($21.2K)
02 Sep 2026	144
24 Aug 2026	Form 4/A: Kovelman Harry, Chief Medical Officer Sold 17,500 shares ($30.3K)
21 Aug 2026	Form 4: Kovelman Harry, Chief Medical Officer Sold 17,250 shares ($29.9K)
20 Aug 2026	144
12 Aug 2026	SCHEDULE 13G/A
11 Aug 2026	Form 4: Kovelman Harry, Chief Medical Officer Received 55,149 shares as a grant or award · Gave up 22,457 shares to cover exercise price or tax ($31.9K)
11 Aug 2026	Form 4: Mitchell Micah, Chief Commercial Officer Received 58,409 shares as a grant or award · Gave up 21,559 shares to cover exercise price or tax ($30.6K)

Comments